Card image cap
Flu vaccine doesn’t aggravate asthma exacerbation in children

Quadrivalent live attenuated influenza vaccine (LAIV4) has been found effective and safe in children aged more than 4 years by not contributing to asthma exacerbations, according to data from a randomised control trial published in Pediatrics. The study analysed 151 children with persistent asthma aged between 5 and 17 years over the course of two influenza seasons to find that 18 children out of the cohort experienced an asthma exacerbation — eight in the LAIV4 group and 10 in the quadrivalent IIV (IIV4) group. There were no significant differences in the frequency of asthma symptoms, change in [peak expiratory flow rate], or childhood asthma control test/asthma control test scores in the 14 days post vaccination between LAIV4 and IIV4 recipients, the researchers wrote.

Content by Future Medicine

Disclaimer :
The author(s)' thoughts and opinions in this article are their own and do not necessarily reflect DocMode's viewpoint. The article is in no way created or edited by DocMode.

Supported by Koye Pharmaceuticals

Submit a Comment